The UNMC College of Medicine faculty received 12 grant awards representing $6.1 million in new funding during the month of April.
Tony Wilson, Ph.D., neurological sciences, has been awarded a NIH P20 award from the National Institute of General Medical Sciences. The $2.3 million award is for the Cognitive Neuroscience of Development and Aging (CoNDA) Center, a Center of Biomedical Research Excellence. The focus of the center will be on human neuroscience research across the lifespan.
Jingwei Xie, Ph.D., transplant surgery, has been issued a Congressionally Directed Medical Research Program award for $1.3 million to develop nanofiber foams for junctional hemorrhage control.
Joshua Santarpia, Ph.D., pathology/microbiology, has received two awards from the Assistant Secretary for Preparedness and Response and the National Strategic Research Institute. The awards, focused on SARS-CoV-2 environmental decontamination, total more than $900,000.
Hanjun Wang, M.D., anesthesiology, has received an NIH R01 from the National Heart, Lung, and Blood Institute. The $539,000 award, “Novel Neural Mechanisms Underlying Lung-Heart Pathological Crosstalk,” will investigate cross-communication between heart and lung motor efferent neurons via immune activation.
Rey Carabeo, Ph.D., pathology/microbiology, has received a $381,000 NIH R01 award from the National Institute of Allergy and Infectious disease. The project, “Chlamydial Invasion of Non-Phagocytic Cells,” will continue investigating the processes of Chlamydia virulence.
Kaustubh Datta, Ph.D., biochemistry and molecular biology, has received a NIH R01 award from the National Cancer Institute. The $348,000 award will investigate the role of neuropilin-2 as a mediator of aggressive prostate cancer, which can be a predictor of poor prognosis.
Roslyn Mannon, M.D., internal medicine-nephrology, has received funding from the National Institute of Allergy and Infectious Disease through the Icahn School of Medicine at Mount Sinai to investigate cell death and rejection in kidney transplant patients.
Industry-sponsored grants and contracts:
The following industry-sponsored contracts and foundation grants were received. Information on clinical trials enrolling patients at UNMC can be found here.
Amy Hellman, M.D., neurological sciences, will be the UNMC lead investigator on an industry-sponsored phase III trial of a novel drug to treat Cholera associated with Huntington’s Disease.
Ashley Deschamp, M.D., pediatrics- pulmonology, has received funding from the Cystic Fibrosis Foundation for a project titled, “Therapeutics Development Center.”
Thomas Porter, M.D., internal medicine- cardiovascular medicine, has received industry funding fo the development of a new ultrasound contrast agent.
Ronald Zolty, M.D., Ph.D., internal medicine- cardiovascular medicine, will be the UNMC lead on a phase IV observational study evaluating the effectiveness of a certain drug in polyneuropathy patients.